Moneycontrol PRO
HomeNewsIndiaIndia needs to get more COVID vaccines, scale up production: Tata Sons Chairman N Chandrasekaran

India needs to get more COVID vaccines, scale up production: Tata Sons Chairman N Chandrasekaran

Chandrasekaran suggested the use of predictive analytics to anticipate pockets where there will be rise in COVID-19 cases, learning from what has happened in Delhi and Mumbai and have a concerted plan to be able to handle those segments.

April 20, 2021 / 09:17 IST
Chairman Tata Group N Chandrasekaran (PC-PTI)

Tata Sons Chairman N Chandrasekaran on Monday said India needs to get as many different COVID-19 vaccine licences as possible and replicate multiple factories on a war footing to ramp up production in order to meet the requirements as the country reels under the devastating second wave of the pandemic.

Terming the second wave as 'concerning and scaring', the head of the over USD 100 billion conglomerate also called for accelerated tracing and vaccination and tracking supply of the vaccines while asserting that a nationwide lockdown is not the solution as it would hit the economy hard and impact people at the lower strata of the society to the largest extent.

"We need to get as many different vaccines licences as possible and we are going to scale up, even if we have to replicate multiple factories," Chandrasekaran said while speaking at an event organised by AIMA. He was responding to a query on how he would have handled the current situation if he were to be given the responsibility.

While terming it as a tough question, he added, "We have to really do this on a war footing..." Also, whatever investments are required need to be done in a short span so as to be able to scale up production, he emphasised.
"We need to figure out how we replicate, how do we mass produce, so that we are able to meet the requirement because this is something that needs to be done. It is an urgent situation," Chandrasekaran said. The immediate thing that can be done during this period, he said, "is to do tracing even now and vaccination" and track supply of vaccines.

On April 13, India had fast-tracked emergency use approval for eligible foreign-produced shots against COVID-19, in a move to expand its basket of vaccines and speed up the inoculation drive that got a boost with a third vaccine Sputnik V from Russia getting clearance. Already two vaccines -- Covaxin by Bharat Biotech and Covishield by Serum Institute of India (SII) -- are being used for inoculation in India.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Commenting on the possibility of lockdown and its impact, Chandrasekaran said, "The most important thing now is to manage the current situation very delicately. On the one hand, you have to protect people, you have to ensure that people don't end up in hospitals in large numbers. "At the same time, we protect the economy because there are segments of the society who will suffer so strongly because of severe economic disruptions. That's a fact of reality."

He further said, "We don't have 'either or option' unfortunately. We often like the binaries but this is not a binary option. This has to be carefully managed and we need to vaccinate at a level of urgency that we have never taken in any initiative at that pace. A lot needs to be done."

Stating that "nobody has been able to predict the behaviour of the pandemic in the last 12 months" and several countries have struggled, he said it was not the time for finger pointing.

"It is very unfair to be criticising somebody everyday. The nature of the beast is such that it has a lot of unpredictability. "No one predicted so many variants, we are learning new terms -- variants, mutation, double mutation. Every single day there are new things that we are learning. The way it has ramped up in the last 10 days or 2 weeks has taken everybody by surprise," he said.

However, he suggested the usage of artificial intelligence and predictive analytics based on what has been witnessed in places like Delhi and Mumbai. Chandrasekaran also declined to comment much on the impact of the second wave of the pandemic on the economy, saying "it will be a wrong day today to say too much about the economy because there is a lot of suffering. We need oxygen. We need hospital beds. We need the vaccines. We need Remdesivir. We need so many things... In a manner of speaking, today everybody's attention is to address these things."

He, however, said sectors like airlines and hospitality will take time to recover from the impact of the pandemic. Reiterating that a lockdown is not the solution to the current situation, he said, "If we go on a serious lockdown and these industries (manufacturing and construction) don't function, we are going to hurt the economy big time. When we hurt the economy big time, we will hurt a section of labourers big time, their livelihoods will suffer, which we saw last time."

Chandrasekaran suggested the use of predictive analytics to anticipate pockets where there will be rise in COVID-19 cases, learning from what has happened in Delhi and Mumbai and have a concerted plan to be able to handle those segments. "This is not a nationwide, one solution fits all," he asserted.

PTI
first published: Apr 20, 2021 09:16 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347